• John Houck
• 12 Sep, 2024

Drugmaker Moderna released updated financial projections and has announced plans to reduce research and development costs over the next couple of years. The company predicts sales figures to hit somewhere in the $2.5-$3.5 billion range in 2025. Moderna also expects revenue to grow 25% annually between 2026 and 2028.
Read more...